ANTH
Geode Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-27,321
| Closed | -$8K | – | 4135 |
|
|
2018
Q1 | $8K | Hold |
27,321
| – | – | ﹤0.01% | 4038 |
|
|
2017
Q4 | $45K | Sell |
27,321
-2,014
| -7% | -$3.32K | ﹤0.01% | 3938 |
|
|
2017
Q3 | $42K | Hold |
29,335
| – | – | ﹤0.01% | 3959 |
|
|
2017
Q2 | $47K | Sell |
29,335
-325,837
| -92% | -$522K | ﹤0.01% | 3969 |
|
|
2017
Q1 | $151K | Buy |
355,172
+49,391
| +16% | +$21K | ﹤0.01% | 3734 |
|
|
2016
Q4 | $197K | Buy |
305,781
+26,516
| +9% | +$17.1K | ﹤0.01% | 3628 |
|
|
2016
Q3 | $879K | Buy |
279,265
+34,007
| +14% | +$107K | ﹤0.01% | 3005 |
|
|
2016
Q2 | $757K | Buy |
245,258
+3,254
| +1% | +$10K | ﹤0.01% | 3030 |
|
|
2016
Q1 | $876 | Buy |
242,004
+2,295
| +1% | +$8 | ﹤0.01% | 2952 |
|
|
2015
Q4 | $1.11M | Sell |
239,709
-16,689
| -7% | -$77.4K | ﹤0.01% | 2855 |
|
|
2015
Q3 | $1.56M | Buy |
256,398
+29,018
| +13% | +$177K | ﹤0.01% | 2601 |
|
|
2015
Q2 | $1.96M | Buy |
227,380
+77,312
| +52% | +$666K | ﹤0.01% | 2515 |
|
|
2015
Q1 | $670K | Buy |
150,068
+56,896
| +61% | +$254K | ﹤0.01% | 3062 |
|
|
2014
Q4 | $147K | Hold |
93,172
| – | – | ﹤0.01% | 3696 |
|
|
2014
Q3 | $178K | Hold |
93,172
| – | – | ﹤0.01% | 3607 |
|
|
2014
Q2 | $315K | Hold |
93,172
| – | – | ﹤0.01% | 3361 |
|
|
2014
Q1 | $312K | Hold |
93,172
| – | – | ﹤0.01% | 3343 |
|
|
2013
Q4 | $286K | Sell |
93,172
-214
| -0.2% | -$657 | ﹤0.01% | 3308 |
|
|
2013
Q3 | $375K | Sell |
93,386
-354,933
| -79% | -$1.43M | ﹤0.01% | 3075 |
|
|
2013
Q2 | $208K | Buy |
+448,319
| New | +$208K | ﹤0.01% | 3221 |
|